Infertility is a problem that affects approximately 15% of couples today. Although assisted reproduction techniques are widely used today, only 40-50% of couples who apply can have children with their own genetic structure. Especially in people with premature ovarian failure, the rate of conception does not exceed 5-10% with the treatments applied today. For this reason, many studies are carried out to obtain oocyte from stem cells with their proliferation and differentiation feature. In addition, regenerative cellular therapies that can replace assisted reproductive techniques and correct impaired fertility are also being investigated in both animal and human studies. In recent years, research has been carried out on stem cell-derived extracellular vesicles, which will eliminate immunological problems. In terms of safety and efficacy, clinical studies involving large populations are needed.
infertility premature ovarian failure embryonic stem cells adult stem cells
Birincil Dil | İngilizce |
---|---|
Konular | Sağlık Kurumları Yönetimi |
Bölüm | Review Articles |
Yazarlar | |
Erken Görünüm Tarihi | 18 Mart 2023 |
Yayımlanma Tarihi | 18 Mart 2023 |
Gönderilme Tarihi | 25 Temmuz 2022 |
Kabul Tarihi | 1 Ekim 2022 |
Yayımlandığı Sayı | Yıl 2023 Cilt: 40 Sayı: 1 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.